风华高科: 公司2025年半年度募集资金存放与使用情况的专项报告

Fundraising Overview - The company raised a total of RMB 4,972,899,910.31 through a private placement of A-shares, with a net amount of RMB 4,971,231,532.86 after deducting issuance costs [1][4] - The funds were received on April 8, 2022, and the verification report was issued by Zhongxi Accounting Firm on April 12, 2022 [1][4] Fund Utilization - As of June 30, 2025, the total amount utilized from the raised funds was RMB 3,477,587,407.20, with a remaining balance of RMB 981,614,306.59 [1][4] - The company has not made any early investments or replacements with the raised funds during the reporting period [4][8] Fund Management - The company has established a management system for the raised funds, ensuring compliance with relevant regulations and protecting investor rights [1][4] - A tripartite supervision agreement has been signed with several banks to manage the raised funds in a dedicated account [1][4] Project Updates - The company plans to reduce the investment scale of the Xianghe project to optimize resource allocation and improve fund utilization efficiency [1][4] - The project is expected to reach full operational status by 2026, aligning with the company's strategic development plans [6][7] Remaining Funds - The remaining funds as of June 30, 2025, are all stored in dedicated accounts, with no other uses reported [4][8] - The company has approved the permanent allocation of surplus funds from the "New Monthly Production of 28 Billion Chip Resistors" project to supplement working capital [7][8]